GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease

Objectives: Deficiency in the transcription factor (TF) GLI-Similar 3 (GLIS3) in humans and mice leads to the development of polycystic kidney disease (PKD). In this study, we investigate the role of GLIS3 in the regulation of energy metabolism and mitochondrial functions in relation to its role in...

Full description

Saved in:
Bibliographic Details
Main Authors: Justin B. Collier, Hong Soon Kang, Yun-Gil Roh, Chitrangda Srivastava, Sara A. Grimm, Alan K. Jarmusch, Anton M. Jetten
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877824001832
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846167133447258112
author Justin B. Collier
Hong Soon Kang
Yun-Gil Roh
Chitrangda Srivastava
Sara A. Grimm
Alan K. Jarmusch
Anton M. Jetten
author_facet Justin B. Collier
Hong Soon Kang
Yun-Gil Roh
Chitrangda Srivastava
Sara A. Grimm
Alan K. Jarmusch
Anton M. Jetten
author_sort Justin B. Collier
collection DOAJ
description Objectives: Deficiency in the transcription factor (TF) GLI-Similar 3 (GLIS3) in humans and mice leads to the development of polycystic kidney disease (PKD). In this study, we investigate the role of GLIS3 in the regulation of energy metabolism and mitochondrial functions in relation to its role in normal kidney and metabolic reprogramming in PKD pathogenesis. Methods: Transcriptomics, cistromics, and metabolomics were used to obtain insights into the role of GLIS3 in the regulation of energy homeostasis and mitochondrial metabolism in normal kidney and PKD pathogenesis using GLIS3-deficient mice. Results: Transcriptome analysis showed that many genes critical for mitochondrial biogenesis, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and the tricarboxylic acid (TCA) cycle, including Tfam, Tfb1m, Tfb2m, Ppargc1a, Ppargc1b, Atp5j2, Hadha, and Sdha, are significantly suppressed in kidneys from both ubiquitous and tissue-specific Glis3-deficient mice. ChIP-Seq analysis demonstrated that GLIS3 is associated with the regulatory region of many of these genes, indicating that their transcription is directly regulated by GLIS3. Cistrome analyses revealed that GLIS3 binding loci frequently located near those of hepatocyte nuclear factor 1-Beta (HNF1B) and nuclear respiratory factor 1 (NRF1) suggesting GLIS3 regulates transcription of many metabolic and mitochondrial function-related genes in coordination with these TFs. Seahorse analysis and untargeted metabolomics corroborated that mitochondrial OXPHOS utilization is suppressed in GLIS3-deficient kidneys and showed that key metabolites in glycolysis, TCA cycle, and glutamine pathways were altered indicating increased reliance on aerobic glycolysis and glutamine anaplerosis. These features of metabolic reprogramming may contribute to a bioenergetic environment that supports renal cyst formation and progression in Glis3-deficient mice kidneys. Conclusions: We identify GLIS3 as a novel positive regulator of the transition from aerobic glycolysis to OXPHOS in normal early postnatal kidney development by directly regulating the transcription of mitochondrial metabolic genes. Loss of GLIS3 induces several features of renal cell metabolic reprogramming. Our study identifies GLIS3 as a new participant in an interconnected transcription regulatory network, that includes HNF1B and NRF1, critical in the regulation of mitochondrial-related gene expression and energy metabolism in normal postnatal kidneys and PKD pathogenesis in Glis3-deficient mice.
format Article
id doaj-art-a8e70fb81db8452f9739f621caf1bb2c
institution Kabale University
issn 2212-8778
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj-art-a8e70fb81db8452f9739f621caf1bb2c2024-11-15T06:11:45ZengElsevierMolecular Metabolism2212-87782024-12-0190102052GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney diseaseJustin B. Collier0Hong Soon Kang1Yun-Gil Roh2Chitrangda Srivastava3Sara A. Grimm4Alan K. Jarmusch5Anton M. Jetten6Cell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USACell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USACell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USACell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USAIntegrative Bioinformatics, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USAMetabolomics Core Facility, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USACell Biology Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC, 27709, USA; Corresponding author.Objectives: Deficiency in the transcription factor (TF) GLI-Similar 3 (GLIS3) in humans and mice leads to the development of polycystic kidney disease (PKD). In this study, we investigate the role of GLIS3 in the regulation of energy metabolism and mitochondrial functions in relation to its role in normal kidney and metabolic reprogramming in PKD pathogenesis. Methods: Transcriptomics, cistromics, and metabolomics were used to obtain insights into the role of GLIS3 in the regulation of energy homeostasis and mitochondrial metabolism in normal kidney and PKD pathogenesis using GLIS3-deficient mice. Results: Transcriptome analysis showed that many genes critical for mitochondrial biogenesis, oxidative phosphorylation (OXPHOS), fatty acid oxidation (FAO), and the tricarboxylic acid (TCA) cycle, including Tfam, Tfb1m, Tfb2m, Ppargc1a, Ppargc1b, Atp5j2, Hadha, and Sdha, are significantly suppressed in kidneys from both ubiquitous and tissue-specific Glis3-deficient mice. ChIP-Seq analysis demonstrated that GLIS3 is associated with the regulatory region of many of these genes, indicating that their transcription is directly regulated by GLIS3. Cistrome analyses revealed that GLIS3 binding loci frequently located near those of hepatocyte nuclear factor 1-Beta (HNF1B) and nuclear respiratory factor 1 (NRF1) suggesting GLIS3 regulates transcription of many metabolic and mitochondrial function-related genes in coordination with these TFs. Seahorse analysis and untargeted metabolomics corroborated that mitochondrial OXPHOS utilization is suppressed in GLIS3-deficient kidneys and showed that key metabolites in glycolysis, TCA cycle, and glutamine pathways were altered indicating increased reliance on aerobic glycolysis and glutamine anaplerosis. These features of metabolic reprogramming may contribute to a bioenergetic environment that supports renal cyst formation and progression in Glis3-deficient mice kidneys. Conclusions: We identify GLIS3 as a novel positive regulator of the transition from aerobic glycolysis to OXPHOS in normal early postnatal kidney development by directly regulating the transcription of mitochondrial metabolic genes. Loss of GLIS3 induces several features of renal cell metabolic reprogramming. Our study identifies GLIS3 as a new participant in an interconnected transcription regulatory network, that includes HNF1B and NRF1, critical in the regulation of mitochondrial-related gene expression and energy metabolism in normal postnatal kidneys and PKD pathogenesis in Glis3-deficient mice.http://www.sciencedirect.com/science/article/pii/S2212877824001832GLIS3Metabolic reprogrammingTranscriptionOxidative phosphorylationPolycystic kidney diseaseAerobic glycolysis
spellingShingle Justin B. Collier
Hong Soon Kang
Yun-Gil Roh
Chitrangda Srivastava
Sara A. Grimm
Alan K. Jarmusch
Anton M. Jetten
GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
Molecular Metabolism
GLIS3
Metabolic reprogramming
Transcription
Oxidative phosphorylation
Polycystic kidney disease
Aerobic glycolysis
title GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
title_full GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
title_fullStr GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
title_full_unstemmed GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
title_short GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
title_sort glis3 a novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease
topic GLIS3
Metabolic reprogramming
Transcription
Oxidative phosphorylation
Polycystic kidney disease
Aerobic glycolysis
url http://www.sciencedirect.com/science/article/pii/S2212877824001832
work_keys_str_mv AT justinbcollier glis3anoveltranscriptionalregulatorofmitochondrialfunctionsandmetabolicreprogramminginpostnatalkidneyandpolycystickidneydisease
AT hongsoonkang glis3anoveltranscriptionalregulatorofmitochondrialfunctionsandmetabolicreprogramminginpostnatalkidneyandpolycystickidneydisease
AT yungilroh glis3anoveltranscriptionalregulatorofmitochondrialfunctionsandmetabolicreprogramminginpostnatalkidneyandpolycystickidneydisease
AT chitrangdasrivastava glis3anoveltranscriptionalregulatorofmitochondrialfunctionsandmetabolicreprogramminginpostnatalkidneyandpolycystickidneydisease
AT saraagrimm glis3anoveltranscriptionalregulatorofmitochondrialfunctionsandmetabolicreprogramminginpostnatalkidneyandpolycystickidneydisease
AT alankjarmusch glis3anoveltranscriptionalregulatorofmitochondrialfunctionsandmetabolicreprogramminginpostnatalkidneyandpolycystickidneydisease
AT antonmjetten glis3anoveltranscriptionalregulatorofmitochondrialfunctionsandmetabolicreprogramminginpostnatalkidneyandpolycystickidneydisease